vitexin 2''-O-beta-D-glucoside
8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
Also Known As: Flavosativaside|Vitexin 2''-O-beta-D-glucoside|Vitexin 2''-glucoside|2''-O-Glucosylvitexin|Vitexin 2''-O-glucoside|2 -Glucosylvitexin|Vitexin 2 -glucoside|2 -O-Glucosylvitexin|Vitexin 2 -O-glucoside|2 -O-D-Glucopyranosylvitexin|vitexin-2''-O-beta-D-glucopyranoside|Vitexin 2 -O-beta-D-glucoside|J2.201.333E|8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one|(1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-2-O-beta-D-glucopyranosyl-D-glucitol|4H-1-Benzopyran-4-one, 8-(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-|8-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|4 ,5,7-Trihydroxy-8-(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)flavone|8-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)-4 ,5,7-trihydroxyflavone|(1S)-1,5-anhydro-1-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl)-2-O-beta-D-glucopyranosyl-D-glucitol|(1S)-1,5-Anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-8-yl]-2-O-beta-D-glucopyranosyl-D-glucitol|2-(4-Hydroxyphenyl)-8-(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-5,7-dihydroxy-4H-1-benzopyran-4-one|4H-1-Benzopyran-4-one, 8-(2-O-|A-D-glucopyranosyl-|A-D-glucopyranosyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-|8-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one|8-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyoxan-2-yl)-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one|8-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)-2-(4-hydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one|8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
| Molecular Formula | C27H30O15 |
|---|---|
| Molecular Weight | 594.15845 g/mol |
| LogP | -2.0841 |
| Topological Polar Surface Area | 260.2 Ų |
| Hydrogen Bond Donors | 10 |
| Hydrogen Bond Acceptors | 15 |
| Rotatable Bonds | 6 |
| Exact Mass | 594.15845 |
| Monoisotopic Mass | 594.15845 |
| Heavy Atoms | 42 |
| Complexity | 1471.1172 |
Chemical Identifiers
| CAS Number | 61360-94-9 |
|---|---|
| SMILES | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O |
Product Overview
vitexin 2''-O-beta-D-glucoside (CAS 61360-94-9), with molecular formula C27H30O15 and molecular weight 594.15845 g/mol. IUPAC: 8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one.